Crispr (CRSP) is said to have attracted takeover interest, according to traders, who cited a Betaville "uncooked' alert that was circulating on Monday. The interest may be from a US-based biopharma with a market cap of $100-$200 billion.
Crispr (CRSP) has a market cap of $5 billion.
Crispr (CRSP) is set to present at the Jefferies Global Healthcare Conference on Tuesday.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.